Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume: 5

Indexed in: Scopus, EBSCO.

Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series which covers recent topics related to understanding Alzheimer's disease (AD) that causes dementia and has a ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Recent Clinical Developments in Alzheimer’s Disease

Pp. 83-143 (61)

Xin Yi Choo and Alexandra Grubman


Alzheimer’s disease is the most common neurodegenerative disease. Despite intensive research, promising therapies have failed to translate to the clinic. This chapter will review the prevailing mechanistic hypotheses to explain AD pathogenesis, including the cholinergic, amyloid-cascade, inflammatory and metal dyshomeostasis theories, present an update on the clinical developments in therapies targeting each of the hypotheses, and highlight promising areas requiring further research.


Alzheimer’s disease, Amyloid antibodies, Amyloid cascade hypothesis, Cholinergic hypothesis, Clinical trials, COX inhibitors, Familial, Metal homeostasis, Metal ionophores, Multi-targeting, Neuroinflammation, Secretase modulators, Sporadic.


Level 6 West, Department of Pathology, Medical Building, Grattan St, The University of Melbourne, Parkville 3010, Victoria, Australia.